Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes

Heather A Boyd, Saima Basit, Maria C Harpsøe, Jan Wohlfahrt, Tine Jess, Heather A Boyd, Saima Basit, Maria C Harpsøe, Jan Wohlfahrt, Tine Jess

Abstract

Background and objectives: Existing data on pregnancy complications in inflammatory bowel disease (IBD) are inconsistent. To address these inconsistencies, we investigated potential associations between IBD, IBD-related medication use during pregnancy, and pregnancy loss, pre-eclampsia, preterm delivery, Apgar score, and congenital abnormalities.

Methods: We conducted a cohort study in >85,000 Danish National Birth Cohort women who were pregnant in the period 1996-2002 and had information on IBD, IBD-related medication use (systemic or local corticosteroids, 5-aminosalicylates), pregnancy outcomes and potential confounders. We evaluated associations between IBD and adverse pregnancy/birth outcomes using Cox regression and log-linear binomial regression.

Results: IBD was strongly and significantly associated with severe pre-eclampsia, preterm premature rupture of membranes and medically indicated preterm delivery in women using systemic corticosteroids during pregnancy (hazard ratios [HRs] >7). IBD was also associated with premature preterm rupture of membranes in women using local corticosteroid medications (HR 3.30, 95% confidence interval [CI] 1.33-8.20) and with medically indicated preterm delivery (HR 1.91, 95% CI 0.99-3.68) in non-medicated women. Furthermore, IBD was associated with low 5-minute Apgar score in term infants (risk ratio [RR] 2.19, 95% CI 1.03-4.66). Finally, Crohn's disease (but not ulcerative colitis) was associated with major congenital abnormalities in the offspring (RR 1.85, 95% CI 1.06-3.21). No child with a congenital abnormality born to a woman with IBD was exposed to systemic corticosteroids in utero.

Conclusion: Women with IBD are at increased risk of severe pre-eclampsia, medically indicated preterm delivery, preterm premature rupture of membranes, and delivering infants with low Apgar score and major congenital malformations. These associations are only partly explained by severe disease as reflected by systemic corticosteroid use.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. van der Woude CJ, Kolacek S, Dotan I, Øresland T, Vermeire S, Munkholm P, et al. European evidence-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis. 2010;4: 493–510. 10.1016/j.crohns.2010.07.004
    1. Vermeire S, Carbonnel F, Coulie PG, Geenen V, Hazes JMW, Masson PL, et al. Management of inflammatory bowel disease in pregnancy. J Crohns Colitis. 2012;6: 811–823. 10.1016/j.crohns.2012.04.009
    1. Bortoli A, Pedersen N, Duricova D, D’Inca R, Gionchetti P, Panelli MR, et al. Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003–2006. Aliment Pharmacol Ther. 2011;34: 724–734. 10.1111/j.1365-2036.2011.04794.x
    1. Ajslev TA, Sorensen TIA, Jess T. Maternal inflammatory bowel disease and offspring body size: a prospective cohort study. Inflamm Bowel Dis. 2012;18: 709–717. 10.1002/ibd.21780
    1. Olsen J, Melbye M, Olsen SF, Sørensen TI, Aaby P, Andersen AM, et al. The Danish National Birth Cohort—its background, structure and aim. Scand J Public Health. 2001;29: 300–307.
    1. Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46: 263–268.
    1. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998; 45: 320–323.
    1. Hegyi T, Carbone T, Anwar M, Ostfeld B, Hiatt M, Koons A, et al. The Apgar score and its components in the preterm infant. Pediatrics. 1998;101: 77–81.
    1. Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007;56: 830–837.
    1. Stephansson O, Larsson H, Pedersen L, Kieler H, Granath F, Ludvigsson JF, et al. Crohn's disease in a risk factor for preterm birth. Clin Gastroenterol Hepatol. 2010;8: 509–515. 10.1016/j.cgh.2010.02.014
    1. Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med. 2004;15: 237–241.
    1. Raatikainen K, Mustonen J, Pajala MO, Heikkinen M, Heinonen S. The effects of pre- and post-pregnancy inflammatory bowel disease diagnosis on birth outcomes. Aliment Pharmacol Ther. 2011;33: 333–339. 10.1111/j.1365-2036.2010.04538.x
    1. Nørgård B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K. Disease activity in pregnant women with Crohn's Disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol. 2007;102: 1947–1954.
    1. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol. 2002;97: 641–648.
    1. Nasef NA, Ferguson LR. inflammatory bowel disease and pregnancy: overlapping pathways. Transl Res. 2012;160: 65–83. 10.1016/j.trsl.2011.12.002
    1. Menon R, Fortunato SJ. Infection and the role of inflammation in preterm premature rupture of the membranes. Best Pract Res Clin Obstet Gynaecol. 2007;21: 467–478.
    1. Nørgård B, Puho E, Pedersen L, Czeizel AE, Sørensen HT. Risk of congenital abnormalities in children born to women with ulcerative colitis. Am J Gastroenterol. 2003;98: 2006–2010.
    1. Stephansson O, Larsson H, Pedersen L, Kieler H, Granath F, Ludvigsson JF, et al. Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden. Inflamm Bowel Dis. 2011;17: 795–801. 10.1002/ibd.21369
    1. Nyboe Andersen N, Pasternak B, Basit S, Andersson M, Svanström H, Caspersen S, et al. Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease. JAMA. 2014;311: 2406–2413. 10.1001/jama.2014.5613

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe